Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?

BACKGROUND: Cancer treatment during pregnancy is a growing problem especially now that women delay childbearing. Systemic treatment of these malignancies during pregnancy centers mainly on the anticancer drugs anthracyclines, widely used in treating hematological and breast cancer during pregnancy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Framarino-dei-Malatesta, Marialuisa, Sammartino, Paolo, Napoli, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696726/
https://www.ncbi.nlm.nih.gov/pubmed/29162041
http://dx.doi.org/10.1186/s12885-017-3772-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696726/
https://www.ncbi.nlm.nih.gov/pubmed/29162041
http://dx.doi.org/10.1186/s12885-017-3772-9

Ejemplares similares